MetroLatinoUSA

27798 Posts

ZZ Biotech’s Stroke Drug Moves Closer to Pivotal Phase 3 Clinical Trial as the NIH Awards First Tranche of $30 Million Grant to the Keck School of Medicine of USC

3K3A-APC Granted Fast-Track Designation by FDA with Multinational Clinical Trial to Run Through NIH StrokeNet HOUSTON--(BUSINESS WIRE)--#cardiology--In a significant development for the treatment of acute ischemic stroke, the National Institute of Neurological Disorders and Stroke (NINDS), part of the U.S. National Institutes of Health (NIH), awarded the first $4 million…
Leer más...

World Famous Casinos and Resorts Upgrade Guest Experiences, Streamline Operations and Ensure Secure Connectivity with Extreme Networks

End-to-End Networking Solutions Reduce IT Workload, Provide Backbone for Cutting-Edge Digital Guest Amenities MORRISVILLE, N.C.--(BUSINESS WIRE)--Extreme Networks, Inc. (Nasdaq: EXTR) a leader in cloud-driven networking solutions, today announced that some of the world’s most famous resorts and casinos, including Jackpot Junction Casino Hotel, Resorts World Las Vegas and Wynn Resorts,…
Leer más...

Dedrone Expands Executive Leadership Team

Balaji Tamirisa, Chief Technology Officer and Daniel Anixt, General Counsel join the airspace security company as it enters a period of rapid growth SAN FRANCISCO--(BUSINESS WIRE)--#airspacesecurity--Dedrone, the market leader in smart airspace security, today announced the appointment of Balaji Tamirisa as Chief Technology Officer (CTO) and Daniel Anixt as General…
Leer más...

Another Arrow in the Quiver: Mastercard Strengthens Cybersecurity Consulting Practice With New Cyber Front Threat Simulation Platform

To help customers strengthen their cyber resilience, Mastercard has invested in risk quantification, always-on security monitoring and fraud prevention in recent years PURCHASE, N.Y.--(BUSINESS WIRE)--With global cybercrime expected to cost $10.5 trillion USD annually by 20251, innovating cybersecurity remains critical across industries facing rapid digitization. Today, Mastercard announced the launch…
Leer más...

Drips Announces Executive Promotions

Conversational AI Pioneer Announces Executive Promotions Due to Continued Growth AKRON, Ohio--(BUSINESS WIRE)--Drips is pleased to announce the recent promotion of two of its top-level executives. In the past 12 months, Drips made tremendous strides in capturing market opportunities in key verticals such as healthcare, insurance, and financial services. The…
Leer más...

KKR Leads $200+ Million Growth Investment in Enterprise Identity Protection Leader Semperis

Semperis experiencing hyper-growth attributed to its solutions' unique capability to defend and recover from directory-based attacks combined with the company's incident response expertise HOBOKEN, N.J.--(BUSINESS WIRE)--Semperis, a pioneer in identity-driven cyber resilience for enterprises, today announced it has raised over $200 million in Series C funding led by KKR, with…
Leer más...

Cosette Pharmaceuticals and Alembic Pharmaceuticals Limited Announce the Approval and Launch of a National Brand Equivalent (NBE) of Abreva® (Docosanol Cream 10%) Including the First Approval in the Pump Format

BRIDGEWATER, N.J. & VADODARA, India--(BUSINESS WIRE)--#abreva--Cosette Pharmaceuticals, Inc ("Cosette"), in collaboration with Aleor Dermaceuticals, a wholly owned subsidiary of Alembic Pharmaceuticals (“Alembic”; BSE: 533573), announced that the U.S. Food and Drug Administration (FDA) has approved the Abbreviated New Drug Application (ANDA) for an NBE version of Abreva® (Docosanol cream 10%)…
Leer más...

Best Buy Reports First Quarter Results

Comparable Sales Decreased 8.0% Compared to 37.2% Growth in Q1 FY22 GAAP Diluted EPS of $1.49 Non-GAAP Diluted EPS of $1.57 MINNEAPOLIS--(BUSINESS WIRE)--Best Buy Co., Inc. (NYSE: BBY) today announced results for the 13-week first quarter ended April 30, 2022 (“Q1 FY23”), as compared to the 13-week first quarter ended…
Leer más...

Aldeyra Therapeutics Designates Schirmer Test as Sole Primary Endpoint in Phase 3 TRANQUILITY-2 Trial of Reproxalap in Dry Eye Disease

Selection Follows Post-Hoc Analysis Demonstrating Statistical Significance of Reproxalap Over Vehicle in Ocular Redness in Completed TRANQUILITY Trial LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced the designation of Schirmer test, a measure of tear production, as the sole primary endpoint in the Phase 3 TRANQUILITY-2 clinical trial…
Leer más...